|
| |
|
 |
| |
Management |
Bernhard Ehmer, M.D.
President |
Jeffrey Aronowitz
Vice President, Information Technology |
Brian Batchelder
Vice President and Chief Financial Officer |
Carole Beer
Vice President, Global Quality |
Dorit Buchner-Moell, M.D.
Vice President, Global Clinical Operations |
Alison Chalker
Vice President, Global Regulatory Affairs |
Mark Glick
Vice President, Project and Portfolio Management |
Andreas Harstrick, M.D.
Senior Vice President, Global Medical and Data Sciences and Medical Communication |
|
Tracy Henrikson
Associate Vice President, Corporate Communications |
Michael Hulka
Vice President and General Counsel |
Jerry Kinzel, Ph.D.
Senior Vice President, Biopharmaceutical Operations |
Greg Plowman, M.D., Ph.D.
Senior Vice President, ImClone Research and Vice President, Lilly Oncology Research |
Greg Reynolds
Vice President, Human Resources |
Rudi Scherhag, Ph.D.
Managing Director and Vice President, ImClone Systems International GmbH |
Tim Talomie
Vice President, New Product Planning |
Todd D. Winge
Vice President, Biologics Manufacturing & Technical Operations |
|
|
|
|
|
